海洋贝类提取物对血管平滑肌细胞增殖的影响

采用20％胎牛血清（FBS），碱性成纤维细胞生长因子（bFGF)所诱导的大鼠VSMCs增殖模型，观察了海洋贝类提取物（ESs)对血管平滑肌细胞（VSMCs)增殖的影响。将培养的5－8代细胞接种于96孔板，除正常组加入含0．4％FBS的M199培养液外，其他组均加入含20％FBS培养液（或含50ng/ml bFGF的0．4％FBS培养液），同时给药组分别加入含有25，50，100μl/ml浓度的ESs，孵育48h后，以细胞计数，结晶紫染色及MTT比色法VSMCc生长情况。结果表明，与模型组比较，ESs各剂量组VSMCs的增殖受到明显抑制（P＜0．05，P＜0．01）。ESs对20％FBS和bFGF所致的VSMCs增殖具有明显抑制作用，并存在剂量依赖关系。     

O-GlcNAc修饰水平变化对牛卵母细胞体外成熟的影响

旨在探究O-β-N-乙酰葡糖胺(O-linked beta-N-acetylglucosamine, O-GlcNAc)修饰水平变化对牛卵母细胞体外成熟的影响。本研究以牛卵母细胞为研究对象,检测O-GlcNAc转移酶(O-GlcNAc transferase, OGT)、O-GlcNAc糖苷酶(O-GlcNAcase, OGA)及O-GlcNAc蛋白在牛体外成熟卵母细胞中的分布;将卵丘-卵母细胞复合体分别在添加4 mmol·L^-1 OGT抑制剂BADGP和100μmol·L^-1 OGA抑制剂PUGNAc的体外成熟液中进行体外成熟,将未添加组作为对照组,分别统计各组卵母细胞第一极体排出率和体外受精胚胎发育率,并采用荧光定量PCR和Western blot检测O-GlcNAc蛋白、OGT、OGA、GFAT和TXNIP的mRNA和蛋白表达。结果表明,OGT和O-GlcNAc蛋白共定位于牛体外成熟卵母细胞的细胞质和细胞核中,而OGA和O-GlcNAc蛋白共定位于体外成熟卵母细胞的细胞质中,且相对集中在卵母细胞的皮质区。与对照组相比,BADGP处理组和...     

猫杯状病毒分离株VP1基因序列与致病性分析

旨在了解上海地区猫杯状病毒(feline calicivirus, FCV)VP1基因与致病性,采用常规方法分离鉴定出13株FCV,经RT-PCR和测序获得分离株VP1的基因序列,与参考株VP1基因进行同源性和遗传演化分析,对2株分离株进行动物致病性试验。结果显示,13株上海地区分离株VP1基因核苷酸序列相互间相似性为74.3%～99.8%,与参考株核苷酸序列和氨基酸序列相似性也较低,符合FCV易突变的特征;进化树分析表明,上海地区FCV流行株主要来自国内北方地区,少数毒株来自国外地区;通过对宿主临床症状、VP1进化树和VS-FCV特征性氨基酸位点进行分析,筛选出7株FCV强毒株;动物致病性试结果验表明,FCV-SH202101株和FCV-SH202113株可导致感染猫发病和死亡,潜伏期为1～2 d,接种后第3天即可检测到排毒,不同年龄段猫的病程不一致,可导致幼猫5 d后死亡,成年猫病程可持续11～18 d, 2株分离株在致病性方面均符合VS-FCV特征。本研究丰富了中国FCV的分子流行病学资料,为VS-FCV毒株的筛选提供了有力的证据,也为FCV疫苗的研究提供了技术支持。     

The use of a real-time PCR primer/probe set to observe infectivity of Yersinia ruckeri in Chinook salmon, Oncorhynchus tshawytscha (Walbaum), and steelhead trout, Oncorhynchus mykiss (Walbaum)

Yersinia ruckeri is the causative agent of enteric redmouth disease (ERM), a common pathogen affecting aquaculture facilities and implicated in large losses of cultured fish. Fisheries scientists continue to gain a greater understanding of the disease and the pathogen by investigating methods of identification and pre- and post-infection treatment. In this study, a real-time PCR probe set for Y. ruckeri was developed to detect daily changes in the bacterial load during pathogen challenges. Two species of fish, Chinook salmon, Oncorhynchus tshawytscha, and steelhead trout, Oncorhynchus mykiss, were exposed to two strains of Y. ruckeri (Hag and SC) during bath challenges. A subset of fish was killed daily for 14 days, and the kidney tissue was biopsied to enumerate copies of pathogen DNA per gram of tissue. While Chinook exposed to either the Hag or SC strains exhibited similar pathogen loads, those exposed to the Hag strain displayed higher mortality (～66%) than fish exposed to the SC strain (～24% mortality). Steelhead exposed to the Hag strain exhibited a greater pathogen load and higher mortality (～42%) than those exposed to the SC strain (<1% mortality). Steelhead challenged with either strain showed lower pathogen loads than Chinook. The study illustrates the efficacy of the probe set to enumerate Y. ruckeri bacterial growth in the kidneys of fish. Also, strains of Y. ruckeri display species-specific growth patterns that result in differential mortality and pathogen load.     

奶牛乳腺上皮细胞三维培养的形态观察

利用原代培养后纯化的奶牛乳腺上皮细胞,以Matrigel为基质胶原,进行奶牛乳腺上皮细胞的三维培养,细胞接种浓度分别为1×104、1×105和1×106个细胞/mL。经过16d培养后,用DAPI对细胞染色,利用荧光显微镜观察细胞生长状况。结果表明,当细胞接种浓度为1×104～1×105个细胞/mL时,细胞形成了团块状结构,出现了类似腔状的腺泡形态。     

牛乳溶菌酶概述及应用

溶菌酶又称胞壁质酶,广泛存在于自然界的动物、植物及微生物中。具有抗菌消炎、抗病毒、增强免疫力以及促进组织修复等生物学特性。并且应用于食品、饲料、医学及生物工程之中。针对目前临床中,对于奶牛乳房炎广泛大量使用抗生素,并且存在耐药性、药物残留等现象。重组溶菌酶质粒可以作为基因工程药物替代抗生素对乳房炎的防治,并且安全、无残留、无副作用。同时也还有待于进一步的研发和推广。     

Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves

Objective To compare the efficacy of the non-steroidal antiinflammatory drugs, diclofenac sodium and flunixin meglumine as adjuncts to the antibiotic treatment of bovine respiratory disease (BRD). Procedure We randomly allocated 80 Holstein calves with BRD to three groups. All the calves received a dose of 2.5 mg/kg tulathromycin by single subcutaneous injection and two of the groups received, in addition, either 2.5 mg/kg diclofenac sodium as a single intramuscular injection (diclofenac group, n = 30) or 2.2 mg/kg flunixin meglumine as an intravenous injection on the first three consecutive days after tulathromycin administration (flunixin group, n = 30). All calves were given a clinical score prior to initial treatment (day 0) and after treatment (days 1, 2, 3, 7 and 14) by observing appetite, demeanour, rectal temperature, the rate and type of respiration, presence or absence of coughing, and nasal discharge. Results During the first 48 h, improvement of adverse signs of respiratory disease, such as pyrexia and elevated respiratory rate, and of a high clinical index score was significant in the two adjunct groups compared with the calves receiving antibiotic alone. The reduction in pyrexia was greatest in the diclofenac group. There were no statically significant differences between treatment groups with regard to eventual perceived recovery from respiratory disease in 14 days. Conclusion In this trial, a single intramuscular dose of diclofenac sodium was equally effective as three intravenous injections of flunixin meglumine given on consecutive days as adjunctive therapy for BRD.     

CASE REPORT: Corneal papilloma associated with papillomavirus in a one‐humped camel (Camelus dromedarius)

A 15‐year‐old male dromedary camel with a history of chronic severe keratoconjunctivitis and corneal mass in the left eye of 6 months’ duration was referred to the Veterinary Medical Teaching Hospital at Adnan Menderes University. A superficial keratectomy was performed and biopsy material submitted for histopathology. The diagnosis was corneal papilloma. There has been no recurrence of the neoplasm to date (6 months, 1 year). Corneal papilloma has not been reported previously in camels and seems to be associated with papillomavirus.     

牛输卵管上皮细胞培养的研究

用０．７６％的ＥＤＴＡ分离剥取输卵管上皮细胞是一种好的试剂，１０％胎牛血清（ＦＣＳ）ＴＣＭ－１９９培养其上皮细胞，５－６ｄ即可生长成单层，寿命可延至３－４周，共同培养从第７天开始，其囊胚发育率显著高于与颗粒细胞共同培养。     

Fumonisin B1 Metabolism by Bovine Liver Microsomes

Only limited and contrasting information is available about the metabolic fate in cattle of fumonisin B₁, a mycotoxin produced by moulds of Fusarium. This study was carried out to evaluate the hepatic metabolism of fumonisin B₁ by bovine liver microsomes. No biodegradation or metabolization of the mycotoxin by liver microsomes was detectable after incubating fumonisin B₁ with bovine microsomes in the presence of a regenerating system for 1 h. No aminopolyol 1, aminopolyol 2 or aminopentol, metabolites of fumonisin B₁, were detected in any of the incubated samples. The tolerance of ruminants to fumonisin B₁ is apparently not dependent on its detoxification in the rumen.